Guanhao Biotech

Zhitong · Oct 28, 2025 at 04:54 AM

Guanhao Biotech released its performance for the first three quarters, with a net profit attributable to the parent company of 26.7185 million yuan, a decrease of 4.02%

Zhitong · Aug 27, 2025 at 05:56 AM

Guanhao Biotech: Net profit of 20.4041 million yuan in the first half of 2025, a year-on-year increase of 1.27%

Zhitong · Jul 31, 2025 at 08:50 PM

Biological vaccine stocks strengthened, among which, Shen Lian Biomedical rose over 10%, Global Printing 10CM hit the daily limit, Guanhao Biotech and Sinovac Biotech rose over 7%, Saili Medical rose over 5%, Kanglao Weishi, Jinhe Biotechnology, and Vland Biotech rose over 4%, Yongshun Biotech, Dezhan Health, Junzheng Group, and Kanghua Biotech rose over 3%

Zhitong · Jul 31, 2025 at 08:42 PM

The concept of innovative drugs remains active, with Xintian Pharma and others hitting the daily limit

Zhitong · Jul 6, 2025 at 08:40 PM

The medical device sector saw a short-term surge, with JG Development hitting the daily limit

Zhitong · Jun 23, 2025 at 06:23 AM

Guanhao Biotech terminates the issuance of stocks to specific objects and withdraws the application documents